ORCID as entered in ROS

Select Publications
1990, 'An audit of oral glucose tolerance test requests', The Medical Journal of Australia, 152, pp. 607 - 608
,1990, 'Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B', Aust N Z J Med, 20, pp. 9 - 19
,1986, 'Are specimens with "at risk" biochemical profiles more likely to be infectious for hepatitis B virus?', Clinical Chemistry, 32, pp. 1951 - 1953
,1986, 'Development of a superior strategy for computer-assisted nucleotide sequence analysis', Nucleic acids research, 14, pp. 47 - 55
,1986, 'Differential co-expression of alpha-actin genes within the human heart.', Journal of Molecular and Cellular Cardiology, 18, pp. 993 - 996
,1986, 'False-positive results with hepatitis B virus DNA dot-hybridization in hepatitis B surface antigen-negative specimens', J Clin Microbiol, 23, pp. 797 - 799
,1986, 'Laboratory tests in acute viral hepatitis', Clinical Biochemistry Reviews, 7, pp. 23 - 29
,1986, 'Rapid method for the concentration of hepatitis B virus particles using Beckman airfuge', J Clin Pathol, 39, pp. 808 - 809
,1986, 'Relationship between hepatitis B virus DNA in blood and serological markers of hepatitis B infection', The Medical Journal of Australia, 144, pp. 351 - 5
,1986, 'Should nucleotide sequence analyzing computer algorithms always extend homologies by extending homologies?', Nucleic acids research, 14, pp. 425 - 430
,1985, 'An exhaustive tree-searching algorithm for high-resolution computer-assisted nucleotide sequence analysis', Computer applications in the biosciences : CABIOS, 1, pp. 153 - 160
,1985, 'Can potentially infectious specimens containing hepatitis B virus be identified on the basis of their biochemical profile?', Clinical Chemistry, 31, pp. 1329 - 1330
,1985, 'Risk factors associated with Hepatitis B infection in antenatal patients', Aust N Z J Med, 15, pp. 641 - 644
,1985, 'Significance of serum and hepatic markers of hepatitis B viral infection in HBsAg-positive and HBsAg-negative chronic active hepatitis', Hepatology, 5, pp. 50 - 53
,1985, 'The risk for perinatal transmission of hepatitis B virus in an Australian obstetrics hospital', Aust N Z J Med, 15, pp. 641 - 644
,1985, 'The SEQANAL and SEQTALK programs: a new method of access to high-resolution nucleotide sequence comparison and analysis programs from a remote laboratory mini- or microcomputer', Computer applications in the biosciences : CABIOS, 1, pp. 241 - 247
,1984, 'Complementary relationship between repetitive sequences in the SV40 early gene pre-promoter enhancing region and big-T antigen splice junction exons', Journal of Theoretical Biology, 110, pp. 533 - 540
,1984, 'Correlation between Hepatitis B Virus DNA and serological markers of hepatitis infection', Aust N Z J Med, 14, pp. 916 - 917 (Suppl)
,1982, 'A model for the mechanism and control of eukaryote gene splicing.', Journal of Theoretical Biology, 97, pp. 351 - 366
,1982, 'Complementary relationship between the SV40 pre-promoter region and the early gene splice junction exon sequences', Proc. 12th International Congress of Biochemistry
,1980, 'A model for the mechanism of splice formation: RNA bridging sequences complementary to the splice junction can appose the RNA exons', Proceedings of the Australian Biochemical Soc, 13, pp. 84 - 84
,1977, 'Initiation and termination of chromosome replication at 45 degree C in a temperature-sensitive deoxyribonucleic acid initiation mutant of Bacillus subtilis 168, TsB134', J Bacteriol, 130, pp. 538 - 539
,2017, 'Predicting the impact of expanded carrier screening on carrier detection rates and healthcare costs', in EUROPEAN JOURNAL OF HUMAN GENETICS, NATURE PUBLISHING GROUP, DENMARK, Copenhagen, pp. 768 - 768, presented at 50th European-Society-of-Human-Genetics (ESHG) Conference, DENMARK, Copenhagen, 27 May 2017 - 30 May 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000489312606275&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2024, '95 Patterns and presentations of mosaic variation in monogenic acquired errors of immunity', in Clinical Immunology, Elsevier BV, Vol. 262, pp. 110037 - 110037, http://dx.doi.org/10.1016/j.clim.2024.110037
,2024, 'Designing and optimising massively multiplex genetic tests for equitable, pan-ancestry reproductive carrier screening: The “Goldilocks” panel', in Clinica Chimica Acta, Elsevier BV, Vol. 558, pp. 119513 - 119513, http://dx.doi.org/10.1016/j.cca.2024.119513
,2024, 'Novel tool for improving the quality of genetic pathology post-analytical reports', in Pathology, Elsevier BV, Vol. 56, pp. S96 - S96, http://dx.doi.org/10.1016/j.pathol.2023.12.324
,2024, 'Novel tool for improving the quality of genetic pathology post-analytical reports', in Clinica Chimica Acta, Elsevier BV, Vol. 558, pp. 119527 - 119527, http://dx.doi.org/10.1016/j.cca.2024.119527
,2024, 'P493: The "Goldilocks" panel: Determining the optimal number of genes for reproductive genetic carrier screening', in Genetics in Medicine Open, Elsevier BV, Vol. 2, pp. 101392 - 101392, http://dx.doi.org/10.1016/j.gimo.2024.101392
,2024, 'The ‘Goldilocks’ panel: determining the optimal number of genes to include for equitable, pan-ancestry carrier screening', in Pathology, Elsevier BV, Vol. 56, pp. S96 - S97, http://dx.doi.org/10.1016/j.pathol.2023.12.325
,2023, 'The myth of the "Genetic Wallflower": in reproductive carrier screening, for every Papageno there is always a Papagena', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, SCOTLAND, Glasgow, Vol. 32, pp. 758 - 758, presented at 56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), SCOTLAND, Glasgow, 10 June 2023 - 13 June 2023
,2022, 'Efficacy of next generation sequencing data reanalysis in unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysis', in GENETICS IN MEDICINE, ELSEVIER SCIENCE INC, TN, Nashville, Vol. 24, pp. S211 - S211, presented at ACMG Annual Clinical Genetics Meeting, TN, Nashville, 22 March 2022 - 26 March 2022, http://dx.doi.org/10.1016/j.gim.2022.01.373
,2021, 'RE-ANALYSIS OF WHOLE GENOME SEQUENCING DATA IN PATIENTS WITH UNDIAGNOSED INBORN ERRORS OF IMMUNITY', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 51, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713717300054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Man vs Machine: Implementing clinically validated automated variant prioritisation with diagnostic performance that equals human experts', in EUROPEAN JOURNAL OF HUMAN GENETICS, NATURE PUBLISHING GROUP, SWEDEN, Gothenburg, Vol. 27, pp. 1079 - 1080, presented at 52nd Conference of the European-Society-of-Human-Genetics (ESHG), SWEDEN, Gothenburg, 15 June 2019 - 18 June 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000489313900083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'CLINICAL IMPACT OF WHOLE GENOME SEQUENCING ON THE DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES - THE CLINICAL IMMUNOGENOMICS RESEARCH CONSORTIUM AUSTRALIA (CIRCA) EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 48, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449673000079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Clinical utility of copy number variant (CNV) detection by whole genome sequencing (WGS)', in EUROPEAN JOURNAL OF HUMAN GENETICS, NATURE PUBLISHING GROUP, ITALY, Milan, Vol. 27, pp. 502 - 502, presented at 51st Conference of the European-Society-of-Human-Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), ITALY, Milan, 16 June 2018 - 19 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000489313104146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Utility of clinical Whole Genome Sequencing (WGS): diagnostic success factors now and into the future', in EUROPEAN JOURNAL OF HUMAN GENETICS, NATURE PUBLISHING GROUP, ITALY, Milan, Vol. 27, pp. 542 - 542, presented at 51st Conference of the European-Society-of-Human-Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), ITALY, Milan, 16 June 2018 - 19 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000489313104228&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Whole genome sequencing in a clinical setting is expanding our understanding of the phenotypic spectrum of rare diseases', in HUMAN GENOMICS, BIOMED CENTRAL LTD, Vol. 12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427728400128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, ClinSV: Clinical grade structural and copy number variant detection from whole genome sequencing data, http://dx.doi.org/10.1101/2020.06.30.20143453
,